Micardis® in Patients With Essential Hypertension
NCT02187705 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 1688
Last updated 2014-07-11
Summary
The aim of this observational study was to supplement the data on efficacy, safety, and tolerability of telmisartan under daily conditions in hospitals
Conditions
Interventions
- DRUG
-
Telmisartan tablets
All patients were treated with different doses of telmisartan for 14 days
Sponsors & Collaborators
- lead INDUSTRY
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 1999-05-31
- Primary Completion
- 2000-05-31
More Related Trials
-
Study to Evaluate Efficacy and Tolerability of Micardis®/Micardis® Plus in Patients With Hypertension
NCT02242357 ·Status: COMPLETED
-
An Observational Study to Investigate the Efficacy, Safety, Tolerability and the Effect on Quality of Life of Telmisartan (Micardis) and Telmisartan With HCTZ (Micardis Plus) in Patients With Hypertension
NCT00904215 ·Status: COMPLETED
-
Post-Marketing Surveillance of Micardis® (Telmisartan) in Patients With Hypertension
NCT02242838 ·Status: COMPLETED
-
Telmisartan Compared to Losartan + Hydrochlorothiazide in Patients With Mild-to-moderate Essential Hypertension
NCT02183701 ·Status: COMPLETED ·Phase: PHASE3
-
Study of Hypertensive Population Under Treatment With Telmisartan in Real Clinical Conditions With the Goal to Control Early Morning Blood Pressure Rise
NCT00946829 ·Status: COMPLETED
-
Post-Marketing Surveillance Study of Micardis® Plus in Patients With Hypertension
NCT02238275 ·Status: COMPLETED
-
Evaluation of the Effect of Telmisartan (Micardis® 80 mg/ MicardisPlus® 80/12.5 mg) on Blood Pressure and Cardiovascular Risk Factor Index in High Risk Hypertensive Patients
NCT00904371 ·Status: COMPLETED
-
Post Marketing Surveillance (PMS) Study to Assess Safety and Efficacy of Micardis in Patients With Essential Hypertension
NCT02245464 ·Status: COMPLETED
-
A Randomized, Double-blind, Parallel-group Assessment of the Safety and Efficacy of Telmisartan 40mg Plus Hydrochlorothiazide 12.5mg (Micardis Plus) in Comparison With Losartan 50mg Plus Hydrochlorothiazide 12.5mg in Taiwanese Patients With Mild to Moderate Hypertension
NCT00133185 ·Status: COMPLETED ·Phase: PHASE3
-
Nice Morning- Safety and Efficacy Observational Study of Telmisartan in Hypertensive Patients in Multicenters
NCT00615108 ·Status: COMPLETED
-
Efficacy and Safety of the Angiotensin II Receptor Antagonist Micardis® (Telmisartan) or Hydrochlorothiazide in the Management of Patients With Isolated Systolic Hypertension (ISH)
NCT02175355 ·Status: COMPLETED ·Phase: PHASE3
-
Telmisartan+HCTZ (Hydrochlorothiazide), Hypertension
NCT00659607 ·Status: COMPLETED
-
Observational Non-interventional Study (Anwendungsbeobachtung) With Telmisartan in High-risk Hypertensives
NCT00539487 ·Status: COMPLETED
-
Safety Evaluation of Telmisartan Plus Hydrochlorothiazide in Patients With Mild-to-Moderate Hypertension
NCT02177487 ·Status: COMPLETED ·Phase: PHASE3
-
Additional Effect of A Life Style Program on Antihypertensive Treatment With Telmisartan
NCT01108796 ·Status: COMPLETED
-
Telmisartan Versus Amlodipine in Patients With Mild-to-Moderate Hypertension
NCT02177409 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Safety, Efficacy and Pharmacokinetics of MICARDIS® (Telmisartan) in Children and Adolescents With Hypertension
NCT02242344 ·Status: COMPLETED ·Phase: PHASE2
-
PROBE Investigation of the Safety & Efficacy of Telmisartan (Micardis®) vs Ramipril (Altace®) Using ABPM in HTN
NCT00274599 ·Status: COMPLETED ·Phase: PHASE4
-
TELSYS - TELmisartan Effectiveness in Isolated SYStolic Hypertension Versus Systolic/Diastolic Hypertension Patients Aged 55 or Older
NCT02242877 ·Status: COMPLETED
-
Efficacy and Safety of Telmisartan and Losartan in Primary Hypertension
NCT02269176 ·Status: COMPLETED ·Phase: PHASE3
-
Evaluation of the Effect of Telmisartan on Blood Pressure Control of High Risk Patients
NCT01108809 ·Status: COMPLETED
-
A Bioequivalence Study Between Telmione 80 mg and Micardis 80 mg in Healthy Adult Volunteers
NCT05223101 ·Status: UNKNOWN ·Phase: PHASE1
-
Telmisartan (Micardis) and Amlodipine (Norvasc) - Factorial Design Study for the Treatment of Hypertension
NCT00281580 ·Status: COMPLETED ·Phase: PHASE3
-
An Observational Cohort Study to Evaluate the Safety and Efficacy of Micardis Tablets Taken Once Daily at 40 mg/Day and 80 mg/Day in Hypertensive Patients Under Real Life Conditions in Usual Clinical Practice
NCT00982735 ·Status: COMPLETED
-
Telmisartan With or Without Hydrochlorothiazide in Patients With Mild-to-moderate Hypertension
NCT02177435 ·Status: COMPLETED ·Phase: PHASE3